Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse

Carcinogenesis

Volumn 31, Issue 2, 2010, Pages 318-325

  Matsumoto, Kojiro ^a   Huang, Jiansheng ^a   Viswakarma, Navin ^a   Bai, Liang ^a   Jia, Yuzhi ^a   Zhu, Yiwei Tony ^a   Yang, Gongshe ^b   Borensztajn, Jayme ^a   Sambasiva Rao, M ^a   Zhu, Yi Jun ^a   Reddy, Janardan K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CRE RECOMBINASE; DIETHYLNITROSAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PHENOBARBITAL; UNCLASSIFIED DRUG; ALKYLATING AGENT; MED1 PROTEIN, MOUSE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; GENE DELETION; GENOTOXICITY; GENOTYPE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; ANIMAL; APOPTOSIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CLONOGENIC ASSAY; DRUG EFFECT; ENZYME IMMUNOASSAY; LIVER TUMOR; METABOLISM; MOUSE MUTANT; NICK END LABELING; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY;

ALKYLATING AGENTS; ANIMALS; APOPTOSIS; COLONY-FORMING UNITS ASSAY; DIETHYLNITROSAMINE; HEPATOCYTES; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; LIVER NEOPLASMS, EXPERIMENTAL; MEDIATOR COMPLEX SUBUNIT 1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE;

EID: 77649209329     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp306     Document Type: Article

References (51)

1. Mangelsdorf, D.J. et al. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
2. Sonoda, J. et al. (2008) Nuclear receptors: decoding metabolic disease. FEBS Lett., 582, 2-9.
3. McKenna, N.J. et al. (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 108, 465-474.
4. Lonard, D.M. et al. (2006) The expanding cosmos of nuclear receptor coactivators. Cell, 125, 411-414.
5. Hermanson, O. et al. (2002) Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol. Metab., 13, 55-60.
6. Kornberg, R.D. (2005) Mediator and the mechanisms of transcriptional activation. Trends Biochem. Sci., 30, 235-239.
7. Onate, S.A. et al. (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science, 270, 1354-1357.
8. Hörlein, A.J. et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature, 377, 387-388.
9. Chen, J.D. et al. (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature, 377, 454-457.
10. Reddy, J.K. et al. (2006) Nuclear receptor transcriptional coactivators in development and metabolism. Adv. Develop. Biol., 16, 389-420.
11. Zhu, Y. et al. (1997) Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem., 272, 25500-25506.
12. Yuan, C.X. et al. (1998) The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl Acad. Sci. USA, 95, 7939-7944.
13. Rachez, C. et al. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature, 398, 824-828.
14. Zhu, Y. et al. (2000) Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality. J. Biol. Chem., 275, 14779-14782.
15. Ito, M. et al. (2000) Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol. Cell, 5, 683-693.
16. Kuang, S.Q. et al. (2002) Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality. J. Biol. Chem., 277, 45356-45360.
17. Zhu, Y.J. et al. (2003) Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J. Biol. Chem., 278, 1986-1990.
18. Mahajan, M.A. et al. (2008) Nuclear receptor coactivator/coregulator NCoA6 (NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development. Nucl. Recept. Signal., 6, 1-19.
19. Antonson, P. et al. (2003) Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol. Cell. Biol., 23, 1260-1268.
20. Xu, J. et al. (1998) Partial hormone resistance in mice with disruption of the steroid receptor coactivator -1 (SRC-1) gene. Science, 279, 1922-1925.
21. Qi, C. et al. (1999) Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor α-regulated gene expression. Proc. Natl Acad. Sci. USA, 96, 1585-1590.
22. Gehin, M. et al. (2002) The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell. Biol., 22, 5923-5937.
23. Wang, Z. et al. (2000) Regulation of somatic growth by the p160 coactivator p/CIP. Proc. Natl Acad. Sci. USA, 97, 13549-13554.
24. Xu, J. et al. (2000) The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl Acad. Sci. USA, 97, 6379-6384.
25. Lin, J. et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell, 119, 121-135.
26. Yadav, N. et al. (2003) Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine mehyltransferase 1-deficient mice. Proc. Natl Acad. Sci. USA, 100, 6464-6468.
27. Jia, Y. et al. (2004) Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARα-regulated gene expression in liver. J. Biol. Chem., 279, 24427-24434.
28. Sarkar, J. et al. (2007) Transcription coactivator PRIP, the peroxisome proliferator-activating receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PPARα and CAR, the constitutive androstane receptor, in mouse liver. Gene Expr., 13, 255-269.
29. Yakar, S. et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl Acad. Sci. USA, 96, 7324-7329.
30. Jia, Y. et al. (2005) Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. Proc. Natl Acad. Sci. USA, 102, 12531-12536.
31. Yu, S. et al. (2007) Transcription coactivators for peroxisome proliferator-activated receptors. Biochim. Biophys. Acta, 1771, 936-951.
32. Matsumoto, K. et al. (2007) Critical role for transcription coactivator peroxisome proliferator-activated receptor PPAR)-binding protein TRAP/220 in liver regeneration and PPARα ligand-induced liver tumor development. J. Biol. Chem., 282, 17053-17060.
33. Reddy, J.K. et al. (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature, 283, 397-398.
34. Neumann, H.-G. (2009) Risk assessment of chemical carcinogens and thresholds. Crit. Rev. Toxicol., 39, 449-461.
35. Diwan, B.A. et al. (1986) Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotions by Phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice. Carcinogenesis, 7, 215-220.
36. Tamano, S. et al. (1994) Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Carcinogenesis, 15, 1791-1798.
37. Kalinichenko, V.V. et al. (2004) Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev., 18, 830-850.
38. Takami, T. et al. (2007) Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine-induced hepatocarcinogenesis. Cancer Res., 67, 9844-9851.
39. Yamamoto, Y. et al. (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res., 64, 7197-7200.
40. Verna, L. et al. (1996) N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol. Ther., 71, 57-81.
41. Kang, J.S. et al. (2007) Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res., 67, 11141-11146.
42. Wei, P. et al. (2000) The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature, 407, 920-923.
43. Swales, K. et al. (2004) CAR, driving into the future. Mol. Endocrinol., 18, 1589-1598.
44. Marx-Stoelting, P. et al. (2009) Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met. Int. J. Cancer, 124, 1767-1772.
45. Kawamoto, T. et al. (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol., 19, 6318-6322.
46. Guo, D. et al. (2006) Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver. Biochem. Biophys. Res. Commun., 347, 485-495.
47. Jia, Y. et al. (2009) Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis. Gene Expr., 14, 291-306
48. Zhu, Y. et al. (1999) Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. Proc. Natl Acad. Sci. USA, 96, 10848-10853.
49. Vijayvargia, R. et al. (2007) A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression. Cancer Res., 67, 4034-4041.
50. Ndong, Jde L. et al. (2009) Down-regulation of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells. Int. J. Cancer, 124, 2597-2606.
51. Zhu, Y.T. et al. (2009) PRIP promotes tumor formation through enhancing serum-responsive factor-mediated FOS expression. J. Biol. Chem., 284, 14485-14492.